ANGARUS THERAPEUTICS
Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patients with a wide range of cancer treatments. Chih-Ping Liu established the company in Sunnyvale, California in 2018.
ANGARUS THERAPEUTICS
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.angarustherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
650-575-1702
Total Funding:
11.32 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Medisyn Technologies
Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
Foothill Ventures
Foothill Ventures investment in Venture Round - Angarus Therapeutics
Official Site Inspections
http://www.angarustherapeutics.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Angarus Therapeutics"
Angarus Therapeutics
Unraveling the complexities of immune-surveillance and immunosuppressive pathways and the associated molecular targets is not an easy task. In collaboration with scientists from Stanford University, our efforts have enabled โฆSee details»
Angarus Therapeutics - Crunchbase Company Profile & Funding
Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The therapy serves as checkpoint blockers on the innate immunity โฆSee details»
Angarus Therapeutics - LinkedIn
At Angarus, we are developing a new class of therapeutics that selectively targets immune-activating and immunosuppressive pathways within the tumor microenvironment, using predictive biomarkers ...See details»
Angarus Therapeutics 2025 Company Profile: โฆ
Angarus Therapeutics General Information Description. Developer of immuno-oncology therapies designed to respond to the urgent needs of cancer treatment. The company's therapies develop checkpoint blockers on the innate immunity โฆSee details»
Angarus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.angarustherapeutics.com. Startups | Holding Company | 2018 | California, United States | 50-100 | www.angarustherapeutics.com. Last update 23 Jan 2025. Overview. Pipeline. ... The โฆSee details»
Who We Are - Angarus Therapeutics
Ed Schnipper, M.D. Acting Chief Medical Officer. Ed is a widely recognized expert in innovative design and management of clinical trials. He is particularly skilled at clinical trials designed โฆSee details»
About - Angarus Therapeutics
Angarus has developed potent and selective small molecule inhibitors of ENPP1 and other ectonucleotidases that modulate tumor immune activity, halting tumor growth and preventing โฆSee details»
Angarus Therapeutics Overview | SignalHire Company Profile
Organization Website: angarustherapeutics.com : Angarus Therapeutics industries Biotech: Angarus Therapeutics Employees Size 100-200 employees: Founded: 2018: Angarus โฆSee details»
Angarus Therapeutics - Products, Competitors, Financials, โฆ
Angarus Therapeutics is engaged in the development of precision oncology therapeutics within the biopharmaceutical sector. Use the CB Insights Platform to explore Angarus Therapeutics's โฆSee details»
Angarus Therapeutics - Overview, News & Similar companies
Popular Searches Angarus Therapeutics Angarus Therapeutics Inc Renesis Therapeutics Inc Angarustherapeutics SIC Code 87,873 NAICS Code 54,541 Show more. Angarus โฆSee details»
Angarus Therapeutics Company Profile -Sales, Contacts, โฆ
Angarus Therapeutics is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 6 years.See details»
Angarus Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Angarus Therapeutics Stock Price, Funding, Valuation, Revenue ...
Angarustherapeutics.com. Overview & Products; Financials; People; Total Raised $11.32M. Investors Count 1. Funding, Valuation & Revenue. 2 Fundings. Angarus Therapeutics has โฆSee details»
Angarus Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 29, 2020: Venture Round - โฆSee details»
Angarus Therapeutics - Contacts, Employees, Board Members, โฆ
Angarus Therapeutics enhances immuno-oncology therapies intended to respond to the urgent needs of cancer treatment.See details»
Angarus Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Angarus Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Sunnyvale California based Angarus Therapeutics is raising โฆ
Jan 19, 2021 Sunnyvale, CA - According to filings with the U.S. Securities and Exchange Commission, Angarus Therapeutics is raising $6,883,438.00 in new funding. Sources indicate โฆSee details»
Angarus Therapeutics | VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, โฆSee details»
Angarus Therapeutics, Inc. (Angarus Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
ไบ่งฃAngarus Therapeutics, Inc. (Angarus Therapeutics, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1็ฏๆฐ้ป๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผๅ ็ซ็ณป็ป็พ็ ๏ผๆๆฏๅนณๅฐ:ๅฐๅๅญๅ่ฏ๏ผๆช็ฅ๏ผ่ฏ โฆSee details»
Angarus Therapeutics Careers - Levels.fyi
Angarus is a company developing targeted cancer therapies that focus on immune-activating and immunosuppressive pathways within the tumor microenvironment.See details»